Case number 1:19-md-02884
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 21, 2021 | 90 | Response to Objections (13) Docket Text: RESPONSE to [88] Objections, by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 7/21/2021 (nms). |
| Jul 9, 2021 | 88 | Objection to Report and Recommendations (14) Docket Text: OBJECTION to [87] Report and Recommendations by FlatWing Pharmaceuticals, LLC. (Phillips, John) |
| Jul 9, 2021 | 89 | Declaration (8) Docket Text: DECLARATION of Don J. Mizerk re [88] Objection to Report and Recommendations, by FlatWing Pharmaceuticals, LLC. (Phillips, John) Modified on 7/9/2021 (nms). |
| Jun 23, 2021 | 87 | Report and Recommendations (7) Docket Text: REPORT AND RECOMMENDATION re Defendant FlatWing Pharmaceuticals, LLC's Motion for Attorney Fees pursuant to 35 U.S.C. § 285 (No. 18-1606-RGA, D.I. 98; No. 19-md-2884-RGA, D.I. 79.) Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/7/2021. The hearing scheduled for June 24, 2021 is CANCELLED. Signed by Judge Jennifer L. Hall on 6/23/2021. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(ceg) |
| Dec 16, 2020 | 86 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by FlatWing Pharmaceuticals, LLC. (Phillips, John) Modified on 12/16/2020 (nms). |
| Dec 15, 2020 | 85 | Main Document (14) Docket Text: REPLY BRIEF re [79] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, filed by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibits S-T)(Phillips, John) Modified on 12/15/2020 (nms). |
| Dec 15, 2020 | 85 | Exhibits S-T (101) |
| Nov 23, 2020 | 83 | Answering Brief in Opposition (26) Docket Text: ANSWERING BRIEF in Opposition re [79] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, filed by Anacor Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 11/30/2020. (Dellinger, Megan) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 84 | Main Document (6) Docket Text: DECLARATION of Anthony H. Sheh re [83] Answering Brief in Opposition, by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits 1-26)(Dellinger, Megan) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 84 | Exhibit 1-26 (659) |
| Oct 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (82 in 19-md-2884-RGA; 101 in 18-cv-1606-RGA) Stipulation and Proposed Order to Extend Time (*Reset Briefing Schedule: re D.I. 79 in 19-md-2884-RGA, and D.I. 98 in 18-cv-1606-RGA)MOTION for Attorney Fees. Answering Brief due 11/23/2020, Reply Brief due 12/14/2020). Signed by Judge Richard G. Andrews on 10/28/2020. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(nms) |
| Oct 28, 2020 | 82 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 10/28/2020 (nms). |
| Oct 26, 2020 | 79 | Main Document (2) Docket Text: MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285 - filed by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Proposed Order, # (2) 7.1.1 Statement)(Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 79 | Text of Proposed Order (1) |
| Oct 26, 2020 | 79 | Rule 7.1.1 Statement (1) |
| Oct 26, 2020 | 80 | Opening Brief in Support (24) Docket Text: OPENING BRIEF in Support re [79] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, filed by FlatWing Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 11/9/2020. (Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 81 | Main Document (5) Docket Text: DECLARATION re [98] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibits A-Q)(Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 81 | Exhibit A - Q (580) |
| Sep 11, 2020 | 77 | Judgment (3) Docket Text: FINAL JUDGMENT is entered in favor of Defendants and against Anacor on Anacor's claims of infringement, and on Defendants' counterclaims of invalidity (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/11/2020. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(nms) |
| Sep 11, 2020 | 78 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290 B2; 9,572,823 B2. (Attachments: # (1) Judgment)(nms) |
| Sep 11, 2020 | 78 | Judgment (3) |
| Sep 10, 2020 | 76 | Main Document (3) Docket Text: PROPOSED Final Judgment, by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Dellinger, Megan) Modified on 9/11/2020 (nms). |
| Sep 10, 2020 | 76 | Letter to Judge Andrews (1) |
| Aug 31, 2020 | 75 | Notice (Other) (4) Docket Text: Joint NOTICE of Federal Circuit Decision by Anacor Pharmaceuticals, Inc. (Dellinger, Megan) |
| Jul 9, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 14 | Motion for Leave to Appear Pro Hac Vice (1) |
| Apr 22, 2020 | 74 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Limited, Lupin Limited; Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Dec 27, 2019 | 72 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Damien Nicholas Tancredi on behalf of Cipla Limited, Cipla USA, Inc. (Tancredi, Damien) |
| Dec 27, 2019 | 73 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jeremy S. Cole as co-counsel. Reason for request: Leaving Firm. (Cole, Jeremy) |
| Dec 16, 2019 | 71 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Paul B. Sudentas as co-counsel. Reason for request: no longer with Locke Lord LLP. (Kraman, Pilar) |
| Oct 28, 2019 | 70 | Order (2) Docket Text: SO ORDERED Granting (D.I. 69 in 19-md-2884-RGA; D.I. 77 in 1:19-cv-00632-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 10/25/2019. Associated Cases: 1:19-md-02884-RGA, 1:19-cv-00632-RGA(nms) |
| Oct 24, 2019 | 69 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal without prejudice, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/24/2019 (nms). |
| Sep 23, 2019 | 68 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove David A. Gerasimow as co-counsel. Reason for request: No longer with Husch Blackwell LLP. (Haney, Megan) |
| Sep 19, 2019 | 66 | Order (3) Docket Text: ORDER TO STAY: The actions are stayed pending Plaintiff's appeal of the PTAB Decisions to the Federal Circuit. The parties will notify the Court of the Federal Circuit's decision no later than three (3) days after it issues. The parties should be prepared to submit with the notification their requests for how to proceed. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 19, 2019 | 67 | Order Administratively Closing Case (2) Docket Text: ORDER: The cases are ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the "Federal Circuit" has resolved the appeal so that these case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 13, 2019 | 64 | Letter (4) |
| Sep 13, 2019 | 64 | Exhibit 1-2 (7) |
| Sep 13, 2019 | 65 | Letter (9) |
| Sep 13, 2019 | 65 | Text of Proposed Order (4) |
| Sep 13, 2019 | 64 | Main Document (4) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Stay. (Attachments: # (1) Exhibit 1-2)(Dellinger, Megan) |
| Sep 13, 2019 | 65 | Main Document (9) Docket Text: Letter to Honorable Richard G. Andrews from Kelly E. Farnan regarding Defendants' Support of Their Stay Proposal. (Attachments: # (1) Text of Proposed Order)(Farnan, Kelly) |
| Aug 27, 2019 | 63 | Order (5) Docket Text: ORDER re (71 in 19-cv-632-RGA, 129 in 18-cv-1673-RGA, 86 in 18-cv-1606-RGA, 62 in 19-md-2884-RGA) Stipulation and Order to File Competing Stay Proposals. Signed by Judge Richard G. Andrews on 8/27/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Aug 26, 2019 | 62 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order to File Competing Stay Proposals by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Aug 14, 2019 | 61 | Stipulation (5) Docket Text: STIPULATION and Order to Amend Scheduling Order by Anacor Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Aug 8, 2019 | N/A | SO ORDERED (0) |
| Aug 7, 2019 | 59 | Stipulation (7) Docket Text: STIPULATION to Amend Scheduling Order by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Aug 7, 2019 | 60 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Anjali Deshmukh as co-counsel. Reason for request: no longer with the firm Wilson Sonsini Goodrich and Rosati. (Palapura, Bindu) |
| Jul 31, 2019 | N/A | SO ORDERED (0) |
| Jul 31, 2019 | 58 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME re: Protective Order to and including August 14, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jul 25, 2019 | N/A | SO ORDERED (0) |
| Jul 24, 2019 | 55 | Notice of Substitution of Counsel (3) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Ascent Pharmaceuticals, Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) |
| Jul 24, 2019 | 56 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of core technical documents (bates numbers ASC_TAV0000001-0002838) filed by Ascent Pharmaceuticals, Inc..(Rogowski, Patricia) |
| Jul 24, 2019 | 57 | Stipulation (7) Docket Text: STIPULATION and Order to Amend Scheduling Order by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Jul 18, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 7/18/2019. (dlb) |
| Jul 17, 2019 | N/A | SO ORDERED (0) |
| Jul 16, 2019 | 53 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME to file a protective order to July 31, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 7/17/2019 (nms). |
| Jun 27, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Flatwing Pharmaceuticals, LLC's Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Defendant Flatwing Pharmaceuticals, LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by FlatWing Pharmaceuticals, LLC.(Phillips, John) |
| Jun 26, 2019 | N/A | Order (0) |
| Jun 26, 2019 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Apotex's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jun 26, 2019 | 51 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel, Michelle M. Ovanesian by Perrigo Company plc, Perrigo Pharma International DAC (Higgins, James) |
| Jun 25, 2019 | 49 | Stipulation (8) Docket Text: STIPULATION and Order to Amend Scheduling Order by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Jun 14, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph M. Janusz for Apotex Corp., for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 13, 2019 | 46 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jun 13, 2019 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| Jun 13, 2019 | 48 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| Jun 11, 2019 | N/A | SO ORDERED (0) |
| Jun 11, 2019 | 44 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| Jun 11, 2019 | 45 | Order (2) Docket Text: SO ORDER Granting (75 in 18-cv-1606-RGA, 43 in 19-md-2884-RGA) Stipulation of Dismissal (*Glasshouse Pharmaceuticals Limited Canada terminated). Signed by Judge Richard G. Andrews on 6/11/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA(nms) |
| Jun 10, 2019 | 43 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Order of Dismissal, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 6/11/2019 (nms). |
| Jun 7, 2019 | 42 | Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Christine M. Braswell as Counsel by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) |
| Jun 4, 2019 | 41 | Order (2) Docket Text: SO ORDERED Granting (40 in 19-md-2884-RGA, 113 in 18-cv-1673-RGA) Stipulation of Dismissal (*Parties Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., terminated). Signed by Judge Richard G. Andrews on 6/3/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01673-RGA(nms) |
| May 31, 2019 | N/A | SO ORDERED (0) |
| May 31, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. 29 has been replaced with an amended version. The caption on the filing has been corrected. (nms) |
| May 31, 2019 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Initial Disclosures under Rule 26(a)(1) and (2) Initial Disclosures under Paragraph 3 of the Default Standard for Discovery filed by Cipla Limited, Cipla USA, Inc..(Cole, Jeremy) |
| May 31, 2019 | 40 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | 26 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Extend Time, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 5/30/2019 (nms). |
| May 30, 2019 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 13, 2019 - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) |
| May 30, 2019 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Mowery, Katharine) |
| May 30, 2019 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Ascent Pharm., Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Ascent Pharm., Inc.s Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ascent Pharmaceuticals, Inc..(Myer, R.) (Main Document 29 replaced on 5/31/2019) (nms). |
| May 30, 2019 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and Mylan Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and the District of Delaware's Default Standard for Discovery filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
| May 30, 2019 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aleor Dermaceuticals Limiteds Initial Disclosures Pursuant to Delawares Default Standard for Discovery and Defendant Aleor Dermaceuticals Limiteds Initial Disclosures filed by Aleor Dermaceuticals Limited.(Harmon, Kate) |
| May 30, 2019 | 32 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Ovanesian, Michelle) |
| May 30, 2019 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Perrigo Pharma International DAC and Perrigo Company plc filed by Perrigo Company plc, Perrigo Pharma International DAC.(Ovanesian, Michelle) |
| May 30, 2019 | 34 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of (1) Anacor's Rule 26(a) Initial Disclosures and (2) Anacor's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
| May 30, 2019 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Under Paragraph 3 of the District of Delaware's Default Standard for Discovery, Including Electronically Stored Information ("ESI") and 2) Defendant Amneal Pharmaceuticals LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Amneal Pharmaceuticals LLC.(Gaza, Anne) |
| May 30, 2019 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Taro Pharmaceuticals U.S.A. and Taro Pharmaceutical Industries, Ltd. Initial Disclosures Under Rule 26(a)(1) and (2) Defendants Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Farnan, Kelly) |
| May 30, 2019 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Encube Ethicals Pvt. Ltd.'s: (1) Initial Disclosures Under Rule 26(a)(1) and (2) Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Encube Ethicals Pvt. Ltd..(Farnan, Kelly) |
| May 30, 2019 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Fed. R. Civ. P. 26(a)(1) Initial Disclosures; and 2) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limiteds Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Braswell, Christine) |
| May 29, 2019 | N/A | SO ORDERED (0) |
| May 29, 2019 | 25 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME extend deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 11, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| May 28, 2019 | 24 | Motion for Extension of Time (2) Docket Text: STIPULATION to Extend Deadlines - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 5/29/2019 (nms). |
| May 17, 2019 | 23 | Answer to Counterclaim (17) Docket Text: ANSWER to [18] Counterclaims, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 5/20/2019 (nms). |
| May 15, 2019 | 22 | Transcript (22) Docket Text: Official Transcript of Scheduling Conference held on 4/25/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/5/2019. Redacted Transcript Deadline set for 6/17/2019. Release of Transcript Restriction set for 8/13/2019. (Triozzi, Heather) |
| May 1, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| May 1, 2019 | 21 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/20/2019. Amended Pleadings due by 12/20/2019. Fact Discovery completed by 7/31/2020. Status Report due by 7/31/2020. Joint Claim Construction Brief due by 3/12/2020. A Markman Hearing is set for 4/13/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/26/2021, at 9:00 AM in Courtroom 6A. A 3-5 day Bench Trial is set to begin 4/12/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 4/30/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Apr 30, 2019 | 20 | Letter (1) |
| Apr 30, 2019 | 20 | Revised Proposed Scheduling Order (13) |
| Apr 30, 2019 | 20 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Revised Proposed Scheduling Order. (Attachments: # (1) Revised Proposed Scheduling Order)(Dellinger, Megan) |
| Apr 26, 2019 | 18 | Answer to Complaint (30) Docket Text: ANSWER to Complaint, Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc., by Glasshouse Pharmaceuticals Limited Canada.(Fry, David) Modified on 4/29/2019 (nms). |
| Apr 26, 2019 | 19 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Contract Pharmaceuticals Limited for Glasshouse Pharmaceuticals Limited Canada filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
| Apr 25, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 4/25/2019. Local counsel present for plaintiff: M. Dellinger. Local counsel present for defendants: P. Kraman, A. Gaza, K. Farnan, D. Moore, K. Mowery, N. Hoeschen, R. Touhey Myer, M. Haney, K. Harmon, K. Dorsney, S. Coyle. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(crb) |
| Apr 24, 2019 | N/A | SO ORDERED (0) |
| Apr 24, 2019 | N/A | SO ORDERED (0) |
| Apr 24, 2019 | N/A | SO ORDERED (0) |
| Apr 24, 2019 | 15 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Margolis - filed by Glasshouse Pharmaceuticals Limited Canada. (Hoeschen, Nathan) |
| Apr 24, 2019 | 16 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Jeremy S. Cole on behalf of Cipla Limited, Cipla USA, Inc. (Cole, Jeremy) |
| Apr 24, 2019 | 17 | Affidavit Andrew Ryan (1) |
| Apr 24, 2019 | 17 | Affidavit Nicholas Geiger (1) |
| Apr 24, 2019 | 17 | Affidavit Steven Coyle (1) |
| Apr 24, 2019 | 17 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven Coyle, Andrew Ryan and Nicholas Geiger - filed by Cipla Limited, Cipla USA, Inc.. (Attachments: # (1) Affidavit Andrew Ryan, # (2) Affidavit Nicholas Geiger, # (3) Affidavit Steven Coyle)(Cole, Jeremy) |
| Apr 23, 2019 | 13 | Letter (1) |
| Apr 23, 2019 | 13 | Proposed Order (13) |
| Apr 23, 2019 | 14 | Certification by Counsel (4) |
| Apr 23, 2019 | 13 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: # (1) Proposed Order)(Dellinger, Megan) Modified on 4/24/2019 (nms). |
| Apr 23, 2019 | 14 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Mark T. Deming, Helena Berezowskyj, and John P. Snow - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Attachments: # (1) Certification by Counsel)(Higgins, James) |
| Apr 22, 2019 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Christine M. Braswell on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Braswell, Christine) |
| Apr 16, 2019 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Moore, David) |
| Apr 16, 2019 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) |
| Apr 15, 2019 | N/A | SO ORDERED (0) |
| Apr 15, 2019 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
| Apr 10, 2019 | 5 | Notice (Other) (9) Docket Text: NOTICE of Appearance of Jack B. Blumenfeld, Megan E. Dellinger and the Law Firm of Morris, Nichols, Arsht & Tunnell LLP by Anacor Pharmaceuticals, Inc. (Dellinger, Megan) |
| Apr 10, 2019 | 6 | ANDA Form (2) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
| Apr 10, 2019 | 7 | ANDA Form (3) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
| Apr 10, 2019 | 8 | ANDA Form (2) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 18, 2018. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
| Apr 5, 2019 | N/A | Oral Order (0) |
| Apr 4, 2019 | N/A | Remark (0) Docket Text: Remark: The following cases in the District of Delaware are included in this MDL: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA and 1:19-cv-00632-RGA (nmg) |
| Apr 4, 2019 | 3 | Letter (1) Docket Text: Letter to the Clerk of USDC/WV, dated 4/4/2019, from the Clerk of USDC/DE, regarding transfer of case 18cv202-IMK. (nmg) Modified on 4/4/2019 (nms). |
| Apr 3, 2019 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 1 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 4/3/19. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 2 | Remark - MDL Notice to Counsel (1) Docket Text: NOTICE TO COUNSEL: MDL No. 1:19-md-2884 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
